| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/25/1996 | CA2193984A1 Chiral synthesis of 2-hydroxy carboxylic acids with a dehydrogenase |
| 01/25/1996 | CA2193263A1 Adenovirus comprising a gene coding for an no synthase |
| 01/25/1996 | CA2192550A1 Chimeric genes and method for increasing the threonine content of the seeds of plants |
| 01/25/1996 | CA2171470A1 Dna encoding phosphoenolpyruvate caboxykinase, recombinant vector and transformed plant containing the same |
| 01/24/1996 | EP0693687A1 Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies |
| 01/24/1996 | EP0693556A1 Transglutaminase originating in japanese oyster |
| 01/24/1996 | EP0693555A1 Potyvirus coat protein genes and plants transformed therewith |
| 01/24/1996 | EP0693554A1 Crucifer aft proteins and uses thereof |
| 01/24/1996 | EP0693551A1 gD-negative bovine herpesvirus mutant, capable of direct cell-to-cell transmission |
| 01/24/1996 | EP0693287A1 RNA cleaving or binding oligonucleotides |
| 01/24/1996 | EP0693286A1 Pharmaceutical composition comprising furin |
| 01/24/1996 | EP0693135A1 Fast dna sequence determination method and use thereof in sequencing and diagnostics |
| 01/24/1996 | EP0693132A1 Rapamycin assay |
| 01/24/1996 | EP0693131A1 Cell free system for protein synthesis and use of chaperone proteins therein |
| 01/24/1996 | EP0693130A1 Targeted delivery of genes encoding antisense polyribonucleotides |
| 01/24/1996 | EP0693129A1 Method of inhibiting the transcription of genes |
| 01/24/1996 | EP0693128A1 Transgenic organism |
| 01/24/1996 | EP0693127A1 Use of tomato e8-derived promoters to express heterologous genes, e.g. s-adenosylmethionine hydrolase, in ripening fruit |
| 01/24/1996 | EP0693126A1 Method for selective inactivation of viral replication |
| 01/24/1996 | EP0693125A1 Fusion proteins between antigenic amino acid sequences and beta-2-microglobulin |
| 01/24/1996 | EP0693124A1 Human osteoclast-specific and -related genes |
| 01/24/1996 | EP0693123A1 Modified oligonucleotides having improved anti-influenza activity |
| 01/24/1996 | EP0693122A1 Glutamylcysteine synthetase light subunit |
| 01/24/1996 | EP0693121A1 Monoclonal antibody 88bv59, subclones and method of making |
| 01/24/1996 | EP0693084A1 Chimeric cytokine receptors in lymphocytes |
| 01/24/1996 | EP0693078A1 Dna polymerases with enhanced thermostability and enhanced length and efficiency of primer extension |
| 01/24/1996 | EP0692968A1 Urokinase plasminogen activator fragments |
| 01/24/1996 | EP0692930A1 Oligonucleotide therapies for modulating the effects of herpesviruses |
| 01/24/1996 | EP0669897A4 Separation of nucleic acid fragments. |
| 01/24/1996 | EP0451216B1 Humanized immunoglobulins and their production and use |
| 01/24/1996 | EP0440619B1 Antibody to a4 amyloid peptide |
| 01/24/1996 | EP0389564B1 Detection of salmonella |
| 01/23/1996 | US5486602 Genes encoding serine protease mutants of the chymotrypsin superfamily resistant to inhibition by their cognate inhibitors |
| 01/23/1996 | US5486599 Construction and use of synthetic constructs encoding syndecan |
| 01/23/1996 | US5486472 Polypeptides |
| 01/23/1996 | US5486470 Purified herpes simplex virus protease and methods of purification |
| 01/23/1996 | US5486469 Thermostable Fervidobacterium pullulanases |
| 01/23/1996 | US5486463 TNF-muteins |
| 01/23/1996 | US5486462 Differentiative expression modules |
| 01/23/1996 | US5486456 Method of diagnosing ovarian, endometrial, and colon cancers with monoclonal antibodies OXA and OXB |
| 01/23/1996 | US5486453 Antibodies to human papillomavirus latent proteins, diagnostic systems and methods |
| 01/23/1996 | US5486351 Method for making stable, extracellular tyrosinase and synthesis of polyphenolic polymers therefrom |
| 01/23/1996 | CA2154379A1 Parietaria allergens |
| 01/23/1996 | CA1337977C Method and materials for the microbial bioconversion of toluene and other phenyl compounds |
| 01/23/1996 | CA1337976C Insulin precursors |
| 01/22/1996 | EP0724447A4 Derivatized oligonucleotides having improved uptake and other properties |
| 01/19/1996 | CA2154030A1 Gd-negative bovine herpesvirus mutant, capable of direct cell-to-cell transmission |
| 01/19/1996 | CA2154019A1 Method for enhancing disease and pest resistance of plants |
| 01/18/1996 | WO1996001425A2 Assay for inhibitors of dp-1 and other dp proteins |
| 01/18/1996 | WO1996001324A2 Novel internal ribosome entry site, vector containing same and therapeutical use thereof |
| 01/18/1996 | WO1996001323A1 Alpha amylase from thermomyces lanuginosus |
| 01/18/1996 | WO1996001322A1 Serum paraoxonase |
| 01/18/1996 | WO1996001321A1 RECOMBINANT MONO AND POLY ANTIGENS TO DETECT CYTOMEGALOVIRUS-SPECIFIC IgM IN HUMAN SERA BY ENZYME IMMUNOASSAY |
| 01/18/1996 | WO1996001320A2 Complete genomic sequence of autographa californica nuclear polyhedrosis virus c6 |
| 01/18/1996 | WO1996001319A1 Variants of leukemia inhibitory factor |
| 01/18/1996 | WO1996001318A1 Immunomodulators |
| 01/18/1996 | WO1996001317A2 Mammalian peroxisome proliferator-activated receptors and uses thereof |
| 01/18/1996 | WO1996001316A1 NOVEL GROWTH OR DIFFERENTIATION FACTOR OF THE TGF-β FAMILY |
| 01/18/1996 | WO1996001315A1 Antisense sequence and ribozyme expression cassette |
| 01/18/1996 | WO1996001314A2 Ribozyme library, its production and use |
| 01/18/1996 | WO1996001313A1 Tetracycline-regulated transcriptional modulators |
| 01/18/1996 | WO1996001276A1 Expression of a functional human type i interferon receptor |
| 01/18/1996 | WO1996001274A1 NEW hIL-4 MUTANT PROTEINS USED AS ANTAGONISTS OR PARTIAL AGONISTS OF HUMAN INTERLEUKIN 4 |
| 01/18/1996 | WO1996001271A1 Platelet-endothelial cell adhesion molecule-1 compositions and methods |
| 01/18/1996 | WO1996001270A1 Human elastase iv |
| 01/18/1996 | WO1996001126A1 Multi-stage cascade boosting vaccine |
| 01/18/1996 | WO1996001116A1 Chicken infectious anemia virus vaccine |
| 01/18/1996 | WO1996001102A1 Factor to grow tissue ex vivo |
| 01/18/1996 | WO1996001055A1 Insect control method with genetically engineered biopesticides |
| 01/18/1996 | WO1995034320A3 Methods for inhibiting antigen specific t cell responses |
| 01/18/1996 | DE4425891A1 Mirror for utilisation of solar energy |
| 01/18/1996 | DE4425115A1 Verfahren zur Modifizierung der Stabilität von Antikörpern A method for modifying the stability of antibodies |
| 01/18/1996 | DE4424577A1 Transporter protein for cationic xenobiotic(s) and pharmaceuticals, and related DNA and transformed cells |
| 01/18/1996 | CA2194396A1 Platelet-endothelial cell adhesion molecule-1 compositions and methods |
| 01/18/1996 | CA2194391A1 Human elastase iv |
| 01/18/1996 | CA2194390A1 Serum paraoxonase |
| 01/18/1996 | CA2194169A1 Mammalian peroxisome proliferator-activated receptors and uses thereof |
| 01/18/1996 | CA2194155A1 Novel internal ribosome entry site, vector containing same and therapeutical use thereof |
| 01/18/1996 | CA2194057A1 Factor to grow tissue ex vivo |
| 01/18/1996 | CA2193091A1 Assay for inhibitors of dp-1 and other dp proteins |
| 01/17/1996 | EP0692541A1 Amplification of midivariant DNA templates |
| 01/17/1996 | EP0692540A2 Oligonucleotide primers and probes for detection of bacteria |
| 01/17/1996 | EP0692537A2 Recombinant gibberellin DNA and uses thereof |
| 01/17/1996 | EP0692536A2 IFN-Y production inducing protein and monoclonal antibody of the same |
| 01/17/1996 | EP0692535A1 Oligonucleotides to inhibit the role of isoprenyl protein transferases |
| 01/17/1996 | EP0692534A2 A chromosome integration vector |
| 01/17/1996 | EP0692532A1 Novel polypeptide, dna coding for said polypeptide, recombinant vector containing said dna, recombinant virus prepared using said vector, and use thereof |
| 01/17/1996 | EP0692490A2 Recombinant Alzheimer's amyloid protein protease inhibitor |
| 01/17/1996 | EP0692488A2 Interleukin 4 signal transducers and binding assays |
| 01/17/1996 | EP0692032A1 Suppressor of hiv replication and transcription |
| 01/17/1996 | EP0692031A1 Heterologous antigens in live cell vaccine strains |
| 01/17/1996 | EP0692030A1 Control of plant abscission and pod dehiscence |
| 01/17/1996 | EP0692029A1 Genetically engineered glutaminase and its use in antiviral and anticancer therapy |
| 01/17/1996 | EP0692028A1 Pharmaceuticals based on papillomaviruses |
| 01/17/1996 | EP0692027A1 Expression of beta-2-microglobulin in pichia pastoris |
| 01/17/1996 | EP0692026A1 A human t-cell receptor of the g-protein coupled receptor family |
| 01/17/1996 | EP0692025A1 Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor |
| 01/17/1996 | EP0692024A1 AN $g(a)-GALACTOSIDASE ENZYME |
| 01/17/1996 | EP0691989A1 Biologically active polypeptide fusion dimers |
| 01/17/1996 | EP0691979A1 Novel 5'-substituted nucleosides and oligomers produced therefrom |